In a 70‑year‑old woman with recurrent urinary tract infections who was recently treated with nitrofurantoin (Macrobid) after a short course of cephalexin (Keflex) and now presents with urinary symptoms and a urine dipstick positive for blood, protein, and leukocytes, and who is taking aripiprazole, clonazepam, levothyroxine, phenelzine, and rivaroxaban, what is the appropriate next antimicrobial therapy?

Obtain a Urine Culture Before Starting Antibiotics

Given this patient's recurrent UTI with recent treatment failure and complex medication regimen (including phenelzine and rivaroxaban), you should obtain a urine culture immediately and start empiric treatment with fosfomycin 3g single dose or a 7-day course of an alternative first-line agent, avoiding nitrofurantoin since she recently failed this therapy. 1

Critical Context for This Case

This 70-year-old woman presents with several concerning features that mandate culture-directed therapy:

• Recent treatment failure: Her prior culture showed mixed flora with <10,000 colonies (likely contamination), but she received nitrofurantoin after brief cephalexin exposure. She now has recurrent symptoms within 2 weeks. 1

• Elderly patient with atypical presentation risk: Older women frequently present with atypical UTI symptoms, and genitourinary symptoms are not necessarily related to cystitis in this age group. 1

• High-risk medication interactions: She is on phenelzine (MAOI) and rivaroxaban, requiring careful antibiotic selection. 1

Immediate Management Algorithm

Step 1: Obtain Urine Culture NOW

For women whose symptoms do not resolve or recur within 2-4 weeks after treatment completion, urine culture and antimicrobial susceptibility testing must be performed. 1 This is a strong recommendation from the 2024 European Association of Urology guidelines. 1

Step 2: Empiric Antibiotic Selection

Since she recently failed nitrofurantoin therapy, assume the infecting organism is not susceptible to the originally used agent and select a different antimicrobial class for a 7-day course. 1

First-line options for this recurrent case:

• Fosfomycin trometamol 3g single dose - Excellent choice given recent nitrofurantoin failure, though single-dose may be less optimal for recurrent infection 1

• Trimethoprim-sulfamethoxazole 160/800mg twice daily for 7 days - Appropriate if local resistance patterns show <20% resistance 1

• Cefadroxil 500mg twice daily for 3-7 days (or comparable cephalosporin) - Only if local E. coli resistance is <20% 1

Avoid these options:

• Do NOT use nitrofurantoin again - She just failed this therapy, and the FDA label specifically warns that "many patients treated with Macrobid are predisposed to persistence or reappearance of bacteriuria" and recommends selecting "other therapeutic agents with broader tissue distribution" in such cases. 2

• Avoid cephalexin - Recent data shows cefdinir (and by extension, first-generation cephalosporins like cephalexin which she already tried briefly) has higher treatment failure rates compared to alternatives. 3

• Exercise caution with fluoroquinolones - While effective, they should be reserved due to resistance concerns and significant adverse effects in elderly patients. 4, 5, 6

Special Considerations for This Patient

Drug Interaction Concerns

Phenelzine (MAOI) interactions: While most antibiotics are safe with MAOIs, avoid linezolid (not relevant here) and be cautious with any agent that might affect serotonin. The recommended antibiotics above are generally safe. 1

Rivaroxaban considerations: No significant interactions with recommended UTI antibiotics, though trimethoprim-sulfamethoxazole theoretically could increase bleeding risk minimally. Monitor for bleeding signs. 1

Age-Related Factors

This 70-year-old patient requires special attention to:

• Polypharmacy and comorbidities: Treatment plans must account for drug interactions and potential adverse events in frail older individuals. 1

• Renal function: If her creatinine clearance is <30 mL/min, avoid nitrofurantoin entirely (though this is already not being used). For CrCl 30-60 mL/min, nitrofurantoin can be used short-term per updated Beers criteria, but given her recent failure, this is moot. 7, 8

• Atypical symptoms: Ensure she doesn't have upper tract involvement (pyelonephritis) which would require longer therapy. 1

Follow-Up Strategy

If symptoms persist or recur again:

• Repeat urine culture and adjust therapy based on susceptibilities 1

• Consider this as recurrent UTI (rUTI) - defined as ≥2 UTIs in 6 months or ≥3 in 12 months - and implement preventive strategies 1, 9

• Evaluate for complicating factors: While extensive workup (cystoscopy, full abdominal ultrasound) is not routinely indicated in women <40 years without risk factors, consider renal ultrasound in this older patient with recurrent infections 1, 9

Prevention Considerations for Future Management

If she develops true rUTI pattern, evidence-based non-antibiotic prophylaxis options include:

• Vaginal estrogen (if postmenopausal) - RR 0.42 for infection reduction 1, 10
• Cranberry products - RR 0.74, though evidence quality is mixed 1, 10
• D-mannose - RR 0.23 for infection reduction 10
• Increased fluid intake - OR 0.13 for short-term reduction 10

These should be considered before antibiotic prophylaxis given lower adverse effect profiles. 1, 9, 10